Market Overview

Benlysta 2017-2018 U.S. Promotional Audit Report -


The "Benlysta
2017 U.S. Promotional Audit Report"
report has been added to's

The 5 Key Questions Addressed by this Report:

  • How many physicians were reached by Benlysta through reportable
    promotional activity in 2017 to drive use within the Lupus market?
  • What promotional mix was leveraged (e.g., sales rep detailing,
    physician education, and paid speaking) and what was the median spend
    for each type of activity?
  • How does GSK's depth of coverage vary within key specialties (e.g.,
    Rheumatology, Internal Medicine, and Family Medicine) and how does
    this compare to the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Benlysta throughout
    the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for
    Benlysta in 2017?

Data Sources and Methodology:

  • The author leverages company-reported financial transaction data
    disclosed through CMS Open Payments. This data set captures all
    transfers of value (e.g., speaking fees, consulting fees, travel,
    education, and meals) made on behalf of a drug or device manufacturer
    to a physician. More than four years of longitudinal data is available
    - covering payments to more than 975,000 U.S. healthcare professionals.
  • Over 8,400 paid interactions across 2,700 physicians made on behalf of
    Benlysta were carefully examined to support our analysis.
For more information about this report visit

View Comments and Join the Discussion!